MediGait
Walking Improvement for Degenerative Diseases
Company Overview
Snapshot
Founded in October 2008, MediGait operated with 1–10 employees, developing solutions for degenerative diseases. The company's GaitAid device, designed to improve walking ability for patients with Parkinson's disease or multiple sclerosis, was a key product, leveraging virtual reality to provide visual and audible feedback.
Business overview
MediGait specializes in digital health and medical technologies, offering the GaitAid device to assist patients with degenerative diseases like Parkinson's and multiple sclerosis. This innovative device utilizes display glasses with connected earphones that pair with a lightweight control unit, projecting a black-and-white tiled floor onto the wearer's field of vision. The system provides visual and audible feedback to improve stride, serving the chronic patient, neurology, and home care markets with a focus on assistive devices and digital healthcare.
Strategic signal
In February 2015, MediGait announced a novel discovery regarding a physical predictor of freezing in Parkinson's disease. This research highlighted the company's commitment to advancing understanding in neurological conditions and underscored the potential for its technology to contribute to more precise interventions for movement disorders, signaling a deeper scientific validation of its approach.
Log in to access full profile ›Company Intelligence Q&A
- What is the primary product offered by MediGait?
- MediGait offers the GaitAid, a device designed to improve walking ability for patients suffering from Parkinson's disease or multiple sclerosis.
- How does the GaitAid device function?
- The GaitAid device consists of display glasses with connected earphones that pair with a control unit. It projects a black-and-white tiled floor onto the wearer's field of vision, providing visual and audible feedback to improve stride.
- When was MediGait founded?
- MediGait was founded in October 2008.
- What significant discovery did MediGait announce in 2015?
- In February 2015, MediGait announced a novel discovery of a physical predictor of freezing in Parkinson's disease, contributing to the understanding of this neurological condition.
- What is the current status of MediGait?
- MediGait is currently non-active, having ceased to operate in June 2017.